medical device investing Chembio Diagnostics Announces Agreement with Perseus Science to Advance Point-of-Care Concussion Test
medical device investing Chembio Diagnostics and LumiraDx Enter Collaboration to Develop New Point-of-Care Diagnostic Tests for Infectious Diseases
medical device investing Chembio Diagnostics Reports Fourth Quarter and Full Year 2017 Financial Results
Blue Lagoon Secures $2 Million Line of Credit from Nicola Mining Enhancing Financial Flexibility Ahead of Production
